July 02, 2020 Covid-19 divides the biggest medtechs Success or failure on the stock markets this year depended almost entirely on whether a company’s devices could be used to treat coronavirus patients.
March 10, 2020 Few groups have developed Covid-19 diagnostics – but this will change The FDA is loosening its rules on the authorisation of diagnostic tests for the new coronavirus, but it is still some way behind Europe.
January 14, 2019 Led by Tandem, small-cap medtechs pump up the value in 2018 The fastest share price growth in medtech is always recorded by small-caps, but Tandem reached a new extreme last year.